Treatment of patients with restenosis

R. Kornowski, M. K. Hong, M. B. Leon

Research output: Contribution to journalReview articlepeer-review

Abstract

Restenosis after successful coronary balloon angioplasty (PTCA) or stenting, usually within the first 6 months, continues to be a major limitation and a therapeutic challenge. Recent studies have identified negative vascular remodeling (for nonstent transcatheter procedures) and neointimal hyperplasia (for in-stent restenosis) as the mechanisms of restenosis. New therapies, such as coronary stents, atheroablative devices, intracoronary irradiation, and local drug delivery, may improve the treatment of restenosis. This review article discusses the therapeutic options for patients with restenosis after coronary angioplasty or stent implantation.

Original languageEnglish
Pages (from-to)79-90
Number of pages12
JournalContemporary Treatments in Cardiovascular Disease
Volume3
Issue number2
StatePublished - 1998
Externally publishedYes

Fingerprint

Dive into the research topics of 'Treatment of patients with restenosis'. Together they form a unique fingerprint.

Cite this